|
Re: Spreading the gospel....
|
3
|
Resverlogix Corp.
|
Dec 10, 2017 12:17PM
|
|
Share price contest
|
3
|
Resverlogix Corp.
|
Nov 03, 2019 05:19PM
|
|
Re: Good luck and fingers crossed..
|
3
|
Resverlogix Corp.
|
Feb 04, 2021 10:49AM
|
|
Re: Month 10
|
3
|
Zenith Epigenetics
|
Apr 16, 2017 03:49PM
|
|
Re: How big is Beacon's book?
|
3
|
Resverlogix Corp.
|
Nov 16, 2017 12:31PM
|
|
Re: Chinese Takeovers
|
3
|
Zenith Epigenetics
|
Mar 08, 2018 03:59AM
|
|
Re: The journey to the finish line
|
3
|
Resverlogix Corp.
|
May 12, 2018 08:54PM
|
|
Re: Eastern exercised some $0.90 cent warrants
|
3
|
Resverlogix Corp.
|
Aug 10, 2018 02:38AM
|
|
Re: LoC security
|
3
|
Resverlogix Corp.
|
Mar 17, 2017 02:21PM
|
|
Re: The day is not over yet....
|
3
|
Resverlogix Corp.
|
Jun 11, 2018 01:36PM
|
|
Re: Priceless on I.V. Regarding Zenith
|
3
|
Zenith Epigenetics
|
Apr 09, 2017 01:08PM
|
|
Re: US to shell out $1.2B for supplies of Merck's potential Covid-19 antiviral.
|
3
|
Resverlogix Corp.
|
Jun 10, 2021 02:46PM
|
|
Re: Broker Meeting 23 Feb
|
3
|
Resverlogix Corp.
|
Mar 01, 2017 09:45AM
|
|
Re: Loan
|
3
|
Resverlogix Corp.
|
Jul 23, 2017 10:37PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 05:55PM
|
|
Re: Extended Betonmace trial
|
3
|
Resverlogix Corp.
|
Apr 21, 2017 03:15PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 06:19PM
|
|
Re: Narmac
|
3
|
Resverlogix Corp.
|
Aug 16, 2024 06:15PM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 19, 2019 05:39PM
|
|
Re: Alternate Universes
|
3
|
Resverlogix Corp.
|
Dec 13, 2019 04:44PM
|
